The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO WCGIC 2023 | Implementing precision medicine approaches in colon cancer
John Marshall, MD, PhD, Lombardi Comprehensive Cancer Center, Georgetown University, WA, discusses the role of precision medicine in the treatment of colon cancer. Gene and protein profiling techniques can optimize treatment options for patients, but additional research is needed to assess who will benefit the most from being tested, and thus eligible for treatment. This interview took place at the ESMO World Congress on Gastrointestinal Cancer (WCGIC) 2023 in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
